Medicare Benefits for Substance Use Disorder and Drug Rehab

Medicare coverage for substance use disorder (SUD) treatment expanded significantly under the Affordable Care Act and subsequent CMS rulemaking, making it a primary payer source for millions of adults aged 65 and older and qualifying individuals with disabilities. This page covers which Medicare parts apply to drug rehab, what services are covered and excluded, how cost-sharing is structured, and the clinical and administrative conditions that determine benefit eligibility. Understanding these boundaries is essential for patients, families, and providers navigating federally funded SUD care.

Definition and scope

Medicare is a federal health insurance program administered by the Centers for Medicare & Medicaid Services (CMS) and authorized under Title XVIII of the Social Security Act. It covers substance use disorder treatment as a defined benefit category, not as an ancillary or optional add-on. The program serves adults 65 and older, individuals under 65 with qualifying disabilities, and people with End-Stage Renal Disease.

Substance use disorder is classified as a medical condition under Medicare's coverage framework. This classification was reinforced by the Mental Health Parity and Addiction Equity Act (MHPAEA), which requires that mental health and SUD benefits not be more restrictive than medical/surgical benefits. Medicare Part A and Part B each carry distinct SUD-relevant provisions; Part D covers medications used in treatment; and Medicare Advantage (Part C) plans must cover all services required under Original Medicare while often adding supplemental benefits.

SUD coverage under Medicare encompasses a defined substance use disorder diagnosis, meaning that diagnostic codes under ICD-10 must support medical necessity. Vague or inadequately documented claims are subject to denial under CMS audit criteria.

How it works

Medicare SUD benefits are distributed across three parts, each governing a different domain of care.

Part A — Inpatient and Residential Services

Part A covers medically necessary inpatient psychiatric and substance abuse treatment in CMS-certified hospitals. Coverage applies to:

1. Acute detoxification requiring 24-hour medical supervision
2. Inpatient psychiatric care for co-occurring disorders
3. Short-term inpatient stays in psychiatric units of general hospitals
4. Inpatient rehabilitation facility stays when criteria are met

Part A does not cover free-standing residential treatment programs unless they hold certification as a hospital-level facility. This is a critical boundary — the majority of dedicated residential drug rehab programs are not Medicare-certified hospitals and therefore fall outside Part A coverage (CMS Medicare Benefit Policy Manual, Chapter 2).

Part B — Outpatient Services

Part B is the primary coverage vehicle for most SUD treatment. Covered services include:

1. Outpatient individual and group therapy for SUD
2. Psychiatric evaluation and medication management
3. Partial hospitalization programs (PHP) when hospital-based or provided in a CMS-certified community mental health center (CMHC)
4. Opioid Treatment Program (OTP) services (a bundled benefit added by CMS in 2020)
5. Annual wellness visits that include SUD screening

The OTP bundled payment rate, established under the final rule published in the Federal Register Vol. 84, No. 217 (2019), covers methadone and buprenorphine dispensing, counseling, toxicology testing, and associated services in a single weekly episode-based rate. Facilities must hold DEA registration and SAMHSA certification to receive this payment (SAMHSA OTP regulations, 42 CFR Part 8).

Part B cost-sharing: 80% of approved costs are paid by Medicare after the annual deductible ($240 in 2024 (CMS Medicare & You 2024)). Beneficiaries are responsible for the remaining 20% coinsurance, which may be covered by Medigap policies.

Part D — Medication Coverage

Part D formularies must include medications approved by the FDA for SUD treatment, including buprenorphine formulations, naltrexone, and acamprosate. Methadone for OUD treatment — distinct from pain management — is covered under the OTP bundle through Part B, not Part D. This distinction is frequently misunderstood and affects where patients receive medication. For deeper detail on medication options, see Medication-Assisted Treatment Overview.

Common scenarios

Scenario 1: Opioid use disorder in a community setting

A Medicare beneficiary with opioid use disorder seeking buprenorphine/Suboxone treatment from an office-based prescriber receives coverage under Part B for physician services and under Part D for the dispensed medication. If that same beneficiary enters a certified OTP that also dispenses methadone, all services are billed under the Part B OTP bundle.

Scenario 2: Alcohol use disorder requiring medical detox

A beneficiary requiring medically supervised detox services is admitted to a general hospital. Part A covers the inpatient stay if the attending physician documents medical necessity for acute stabilization. If the same beneficiary attends outpatient follow-up therapy, Part B covers those sessions.

Scenario 3: Co-occurring psychiatric disorder

A beneficiary with both alcohol use disorder and major depressive disorder may qualify for PHP services. Coverage applies when services are provided in a hospital outpatient department or a SAMHSA/CMS-certified CMHC, the treatment is under physician supervision, and the beneficiary requires a structured level of care that cannot be managed in standard outpatient. See Co-Occurring Disorders and Dual Diagnosis for clinical classification detail.

Scenario 4: Intensive outpatient programs (IOP)

Standard IOPs are not explicitly recognized under Medicare's billing framework the same way PHPs are. Coverage depends on whether services are billed individually under existing Part B codes (individual therapy, group therapy, psychiatric evaluation) rather than as a bundled IOP rate. Facilities that bill an IOP facility fee without a specific Medicare benefit category face claim denials.

Decision boundaries

Not all drug rehab services or settings qualify for Medicare reimbursement. The following structured boundaries define coverage versus non-coverage:

Covered vs. Not Covered: Key Distinctions

SAMHSA Certification and ASAM Criteria

Medicare coverage decisions reference clinical necessity frameworks. The American Society of Addiction Medicine (ASAM) Criteria provide a structured assessment tool used by payers and reviewers to determine appropriate levels of care. While Medicare does not formally adopt ASAM Criteria by name in its benefit rules, CMS contractors routinely reference multidimensional assessment principles when conducting utilization review. The levels of care defined under ASAM criteria map to specific billing contexts that affect coverage outcomes.

Medicare Advantage Variation

Medicare Advantage (Part C) plans must cover all services Original Medicare covers. Advantage plans may offer additional SUD benefits — such as expanded telehealth, transportation to treatment, or recovery support services — but may also impose prior authorization requirements and narrower networks. Plan-level variation is significant. Beneficiaries comparing drug rehab insurance coverage options should verify Advantage plan specifics through the CMS Medicare Plan Finder.

Eligibility Boundaries

Beneficiaries under 65 qualify for Medicare only through Social Security Disability Insurance (SSDI) after a 24-month waiting period or through an End-Stage Renal Disease or ALS diagnosis. SUD alone does not qualify an individual for Medicare disability. This creates a coverage gap for working-age adults with SUD who have not met disability criteria — a population more likely covered by Medicaid or Affordable Care Act marketplace plans.

The Fiscal Responsibility Act of 2023 (Pub. L. 118-5, enacted June 3, 2023) suspended the federal debt limit through January 1, 2025, and established caps on discretionary spending. The Act does not directly amend Medicare SUD benefits; however, its discretionary spending constraints may affect future CMS program funding and administrative capacity. Beneficiaries seeking information about any downstream effects on Medicare-covered SUD services should monitor updates from the Centers for Medicare & Medicaid Services and the Social Security Administration.

References

• Centers for Medicare & Medicaid Services (CMS)
• CMS Medicare Benefit Policy Manual, Chapter 2 — Inpatient Psychiatric Hospital Services
• CMS Medicare & You 2024 Handbook
• Federal Register Vol. 84, No. 217 — CY 2020 Physician Fee Schedule Final Rule (OTP Benefit)
• SAMHSA — Opioid Treatment Program (OTP) Regulations, 42 CFR Part 8
• Fiscal Responsibility Act of 2023, Pub. L. 118-5 (enacted June 3, 2023)
• Social Security Administration